[{"id":"b150f7b0-fa0a-4051-89d4-8cd9aed4ac61","acronym":"NVG111-101","url":"https://clinicaltrials.gov/study/NCT04763083","created_at":"2021-02-21T13:52:27.874Z","updated_at":"2024-07-02T16:35:43.724Z","phase":"Phase 1","brief_title":"First in Human Study of NVG-111 in Relapsed/Refractory ROR1+ Malignancies","source_id_and_acronym":"NCT04763083 - NVG111-101","lead_sponsor":"NovalGen Ltd.","biomarkers":" ROR1","pipe":"","alterations":" ","tags":["ROR1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e NVG-111"],"overall_status":"Recruiting","enrollment":" Enrollment 90","initiation":"Initiation: 05/14/2021","start_date":" 05/14/2021","primary_txt":" Primary completion: 12/01/2023","primary_completion_date":" 12/01/2023","study_txt":" Completion: 12/01/2025","study_completion_date":" 12/01/2025","last_update_posted":"2023-07-07"}]